Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 731

1.

Early planned removal of umbilical venous catheters to prevent infection in newborn infants.

Gordon A, Greenhalgh M, McGuire W.

Cochrane Database Syst Rev. 2017 Oct 10;10:CD012142. doi: 10.1002/14651858.CD012142.pub2. Review.

PMID:
29017005
2.

Protein hydrolysate versus standard formula for preterm infants.

Ng DHC, Klassen J, Embleton ND, McGuire W.

Cochrane Database Syst Rev. 2017 Oct 2;10:CD012412. doi: 10.1002/14651858.CD012412.pub2. Review.

PMID:
28968486
3.

Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.

Izumchenko E, Paz K, Ciznadija D, Sloma I, Katz A, Vasquez-Dunddel D, Ben-Zvi I, Stebbing J, McGuire W, Harris W, Maki R, Gaya A, Bedi A, Zacharoulis S, Ravi R, Wexler LH, Hoque MO, Rodriguez-Galindo C, Pass H, Peled N, Davies A, Morris R, Hidalgo M, Sidransky D.

Ann Oncol. 2017 Oct 1;28(10):2595-2605. doi: 10.1093/annonc/mdx416.

PMID:
28945830
4.

High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants.

Abiramalatha T, Thomas N, Gupta V, Viswanathan A, McGuire W.

Cochrane Database Syst Rev. 2017 Sep 12;9:CD012413. doi: 10.1002/14651858.CD012413.pub2. Review.

PMID:
28898404
5.

Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future.

Fields EC, McGuire WP, Lin L, Temkin SM.

Front Oncol. 2017 Aug 21;7:177. doi: 10.3389/fonc.2017.00177. eCollection 2017. Review.

6.

Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Oddie SJ, Young L, McGuire W.

Cochrane Database Syst Rev. 2017 Aug 30;8:CD001241. doi: 10.1002/14651858.CD001241.pub7. Review.

PMID:
28854319
7.

Decision making in advanced heart failure: bench, bedside, practice, and policy.

Matlock DD, McGuire WC, Magid M, Allen L.

Heart Fail Rev. 2017 Sep;22(5):559-564. doi: 10.1007/s10741-017-9631-6. Review.

PMID:
28670652
8.

Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials.

Embleton ND, Berrington JE, Dorling J, Ewer AK, Juszczak E, Kirby JA, Lamb CA, Lanyon CV, McGuire W, Probert CS, Rushton SP, Shirley MD, Stewart CJ, Cummings SP.

Front Nutr. 2017 May 8;4:14. doi: 10.3389/fnut.2017.00014. eCollection 2017.

9.

Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.

Teng PN, Bateman NW, Wang G, Litzi T, Blanton BE, Hood BL, Conrads KA, Ao W, Oliver KE, Darcy KM, McGuire WP, Paz K, Sidransky D, Hamilton CA, Maxwell GL, Conrads TP.

Hum Cell. 2017 Jul;30(3):226-236. doi: 10.1007/s13577-017-0162-1. Epub 2017 Mar 1.

PMID:
28251557
10.

The Speed of Increasing milk Feeds: a randomised controlled trial.

Abbott J, Berrington J, Bowler U, Boyle E, Dorling J, Embleton N, Juszczak E, Leaf A, Linsell L, Johnson S, McCormick K, McGuire W, Roberts T, Stenson B; Sift Investigators Group.

BMC Pediatr. 2017 Jan 28;17(1):39. doi: 10.1186/s12887-017-0794-z.

11.

Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing.

Devane D, Lalor JG, Daly S, McGuire W, Cuthbert A, Smith V.

Cochrane Database Syst Rev. 2017 Jan 26;1:CD005122. doi: 10.1002/14651858.CD005122.pub5. Review.

PMID:
28125772
12.

Nutrient-enriched formula versus standard formula for preterm infants following hospital discharge.

Young L, Embleton ND, McGuire W.

Cochrane Database Syst Rev. 2016 Dec 13;12:CD004696. doi: 10.1002/14651858.CD004696.pub5. Review.

PMID:
27958643
13.

Responsive versus scheduled feeding for preterm infants.

Watson J, McGuire W.

Cochrane Database Syst Rev. 2016 Aug 31;(8):CD005255. doi: 10.1002/14651858.CD005255.pub5. Review.

PMID:
27580199
14.

Peripherally Inserted Central Catheters vs Peripheral Cannulas for Delivering Parenteral Nutrition in Neonates.

Ainsworth SB, McGuire W.

JAMA. 2016 Jun 21;315(23):2612-3. doi: 10.1001/jama.2016.7020.

PMID:
27327804
15.

Phase I study of pemetrexed with sorafenib in advanced solid tumors.

Poklepovic A, Gordon S, Shafer DA, Roberts JD, Bose P, Geyer CE Jr, McGuire WP, Tombes MB, Shrader E, Strickler K, Quigley M, Wan W, Kmieciak M, Massey HD, Booth L, Moran RG, Dent P.

Oncotarget. 2016 Jul 5;7(27):42625-42638. doi: 10.18632/oncotarget.9434.

16.

Multi-nutrient fortification of human milk for preterm infants.

Brown JV, Embleton ND, Harding JE, McGuire W.

Cochrane Database Syst Rev. 2016 May 8;(5):CD000343. doi: 10.1002/14651858.CD000343.pub3. Review.

PMID:
27155888
17.

Early removal versus expectant management of central venous catheters in neonates with bloodstream infection.

Vasudevan C, Oddie SJ, McGuire W.

Cochrane Database Syst Rev. 2016 Apr 20;4:CD008436. doi: 10.1002/14651858.CD008436.pub3. Review.

PMID:
27095103
18.

Glutamine supplementation to prevent morbidity and mortality in preterm infants.

Moe-Byrne T, Brown JV, McGuire W.

Cochrane Database Syst Rev. 2016 Apr 18;4:CD001457. doi: 10.1002/14651858.CD001457.pub6. Review.

PMID:
27089158
19.

[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling.

Booth L, Roberts JL, Tavallai M, Chuckalovcak J, Stringer DK, Koromilas AE, Boone DL, McGuire WP, Poklepovic A, Dent P.

Oncotarget. 2016 Apr 26;7(17):23608-32. doi: 10.18632/oncotarget.8281.

20.

Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.

Tavallai M, Booth L, Roberts JL, McGuire WP, Poklepovic A, Dent P.

Oncotarget. 2016 Apr 5;7(14):17290-300. doi: 10.18632/oncotarget.8039.

21.

Impact of molecular profiling on overall survival of patients with advanced ovarian cancer.

Herzog TJ, Spetzler D, Xiao N, Burnett K, Maney T, Voss A, Reddy S, Burger R, Krivak T, Powell M, Friedlander M, McGuire W.

Oncotarget. 2016 Apr 12;7(15):19840-9. doi: 10.18632/oncotarget.7835.

22.

The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling.

Booth L, Roberts JL, Tavallai M, Webb T, Leon D, Chen J, McGuire WP, Poklepovic A, Dent P.

Oncotarget. 2016 Apr 12;7(15):19620-30. doi: 10.18632/oncotarget.7746.

23.

Topical emollient for preventing infection in preterm infants.

Cleminson J, McGuire W.

Cochrane Database Syst Rev. 2016 Jan 29;(1):CD001150. doi: 10.1002/14651858.CD001150.pub3. Review.

PMID:
26824786
24.

Glutamine supplementation to prevent morbidity and mortality in preterm infants.

Moe-Byrne T, Brown JV, McGuire W.

Cochrane Database Syst Rev. 2016 Jan 12;(1):CD001457. doi: 10.1002/14651858.CD001457.pub5. Review. Update in: Cochrane Database Syst Rev. 2016;4:CD001457.

PMID:
26755330
25.

Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.

Austin N, Cleminson J, Darlow BA, McGuire W.

Cochrane Database Syst Rev. 2015 Oct 24;(10):CD003478. doi: 10.1002/14651858.CD003478.pub5. Review.

PMID:
26497202
26.

Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

Cleminson J, Austin N, McGuire W.

Cochrane Database Syst Rev. 2015 Oct 24;(10):CD003850. doi: 10.1002/14651858.CD003850.pub5. Review.

PMID:
26497056
27.

Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Morgan J, Young L, McGuire W.

Cochrane Database Syst Rev. 2015 Oct 15;(10):CD001241. doi: 10.1002/14651858.CD001241.pub6. Review. Update in: Cochrane Database Syst Rev. 2017 Aug 30;8:CD001241.

PMID:
26469124
28.

Responsive versus scheduled feeding for preterm infants.

Watson J, McGuire W.

Cochrane Database Syst Rev. 2015 Oct 13;(10):CD005255. doi: 10.1002/14651858.CD005255.pub4. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD005255.

PMID:
26459238
29.

Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates.

Ainsworth S, McGuire W.

Cochrane Database Syst Rev. 2015 Oct 6;(10):CD004219. doi: 10.1002/14651858.CD004219.pub4. Review.

PMID:
26439610
30.

Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance.

Webb T, Carter J, Roberts JL, Poklepovic A, McGuire WP, Booth L, Dent P.

Cancer Biol Ther. 2015;16(11):1660-70. doi: 10.1080/15384047.2015.1099769. Epub 2015 Sep 29.

31.

Antimicrobial-impregnated central venous catheters for prevention of catheter-related bloodstream infection in newborn infants.

Balain M, Oddie SJ, McGuire W.

Cochrane Database Syst Rev. 2015 Sep 27;(9):CD011078. doi: 10.1002/14651858.CD011078.pub2. Review.

PMID:
26409791
32.

Randomization methods in emergency setting trials: a descriptive review.

Corbett MS, Moe-Byrne T, Oddie S, McGuire W.

Res Synth Methods. 2016 Mar;7(1):46-54. doi: 10.1002/jrsm.1163. Epub 2015 Sep 2. Review.

33.

Topical emollient for prevention of infection in preterm infants: a systematic review.

Cleminson J, McGuire W.

Lancet. 2015 Feb 26;385 Suppl 1:S31. doi: 10.1016/S0140-6736(15)60346-4.

PMID:
26312853
34.

Genotyping Informatics and Quality Control for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort.

Kvale MN, Hesselson S, Hoffmann TJ, Cao Y, Chan D, Connell S, Croen LA, Dispensa BP, Eshragh J, Finn A, Gollub J, Iribarren C, Jorgenson E, Kushi LH, Lao R, Lu Y, Ludwig D, Mathauda GK, McGuire WB, Mei G, Miles S, Mittman M, Patil M, Quesenberry CP Jr, Ranatunga D, Rowell S, Sadler M, Sakoda LC, Shapero M, Shen L, Shenoy T, Smethurst D, Somkin CP, Van Den Eeden SK, Walter L, Wan E, Webster T, Whitmer RA, Wong S, Zau C, Zhan Y, Schaefer C, Kwok PY, Risch N.

Genetics. 2015 Aug;200(4):1051-60. doi: 10.1534/genetics.115.178905. Epub 2015 Jun 19.

35.

Automated Assay of Telomere Length Measurement and Informatics for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort.

Lapham K, Kvale MN, Lin J, Connell S, Croen LA, Dispensa BP, Fang L, Hesselson S, Hoffmann TJ, Iribarren C, Jorgenson E, Kushi LH, Ludwig D, Matsuguchi T, McGuire WB, Miles S, Quesenberry CP Jr, Rowell S, Sadler M, Sakoda LC, Smethurst D, Somkin CP, Van Den Eeden SK, Walter L, Whitmer RA, Kwok PY, Risch N, Schaefer C, Blackburn EH.

Genetics. 2015 Aug;200(4):1061-72. doi: 10.1534/genetics.115.178624. Epub 2015 Jun 19.

36.

Antenatal magnesium sulfate: Neuro-protection for preterm infants.

Oddie S, Tuffnell DJ, McGuire W.

Arch Dis Child Fetal Neonatal Ed. 2015 Nov;100(6):F553-7. doi: 10.1136/archdischild-2014-307655. Epub 2015 Apr 20. Review.

PMID:
25896966
37.

A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group study.

Coleman RL, Sill MW, Thaker PH, Bender DP, Street D, McGuire WP, Johnston CM, Rotmensch J.

Gynecol Oncol. 2015 Jul;138(1):30-5. doi: 10.1016/j.ygyno.2015.04.005. Epub 2015 Apr 14.

38.

Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients.

Bateman NW, Jaworski E, Ao W, Wang G, Litzi T, Dubil E, Marcus C, Conrads KA, Teng PN, Hood BL, Phippen NT, Vasicek LA, McGuire WP, Paz K, Sidransky D, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP.

J Proteome Res. 2015 Apr 3;14(4):1900-10. doi: 10.1021/pr5012894. Epub 2015 Mar 19.

39.

Reply to T.j. Herzog et Al.

McGuire WP.

J Clin Oncol. 2015 May 1;33(13):1512. doi: 10.1200/JCO.2014.60.3571. Epub 2015 Mar 2. No abstract available.

PMID:
25732173
40.

Active versus expectant management for women in the third stage of labour.

Begley CM, Gyte GM, Devane D, McGuire W, Weeks A.

Cochrane Database Syst Rev. 2015 Mar 2;(3):CD007412. doi: 10.1002/14651858.CD007412.pub4. Review.

PMID:
25730178
41.

Glutamine supplementation for young infants with severe gastrointestinal disease.

Brown JV, Moe-Byrne T, McGuire W.

Cochrane Database Syst Rev. 2014 Dec 15;(12):CD005947. doi: 10.1002/14651858.CD005947.pub4. Review.

PMID:
25504522
42.

Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Morgan J, Young L, McGuire W.

Cochrane Database Syst Rev. 2014;(12):CD001241. doi: 10.1002/14651858.CD001241.pub5. Epub 2014 Dec 2. Review. Update in: Cochrane Database Syst Rev. 2015;(10):CD001241.

PMID:
25452221
43.

Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.

Morgan J, Young L, McGuire W.

Cochrane Database Syst Rev. 2014;(12):CD001970. doi: 10.1002/14651858.CD001970.pub5. Epub 2014 Dec 1. Review.

PMID:
25436902
44.

Being baby friendly: evidence-based breastfeeding support.

Cleminson J, Oddie S, Renfrew MJ, McGuire W.

Arch Dis Child Fetal Neonatal Ed. 2015 Mar;100(2):F173-8. doi: 10.1136/archdischild-2013-304873. Epub 2014 Oct 7. Review.

PMID:
25293712
45.

Ovarian cancer and antiangiogenic therapy: caveat emptor.

Oliver KE, McGuire WP.

J Clin Oncol. 2014 Oct 20;32(30):3353-6. doi: 10.1200/JCO.2014.57.4574. Epub 2014 Sep 15. No abstract available.

PMID:
25225422
46.

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.

Penson RT, Moore KM, Fleming GF, Braly P, Schimp V, Nguyen H, Matulonis UA, Banerjee S, Haluska P, Gore M, Bodurka DC, Hozak RR, Joshi A, Xu Y, Schwartz JD, McGuire WP.

Gynecol Oncol. 2014 Sep;134(3):478-85. doi: 10.1016/j.ygyno.2014.06.029. Epub 2014 Jul 10.

47.

Formula versus donor breast milk for feeding preterm or low birth weight infants.

Quigley M, McGuire W.

Cochrane Database Syst Rev. 2014 Apr 22;(4):CD002971. doi: 10.1002/14651858.CD002971.pub3. Review.

PMID:
24752468
48.

Current approaches and challenges in managing and monitoring treatment response in ovarian cancer.

Marcus CS, Maxwell GL, Darcy KM, Hamilton CA, McGuire WP.

J Cancer. 2014 Jan 1;5(1):25-30. doi: 10.7150/jca.7810. Review.

49.

Lactose avoidance for young children with acute diarrhoea.

MacGillivray S, Fahey T, McGuire W.

Cochrane Database Syst Rev. 2013 Oct 31;(10):CD005433. doi: 10.1002/14651858.CD005433.pub2. Review.

PMID:
24173771
50.

HE4--another marker for gynecologic cancers: do we really need one?

McGuire WP.

Oncology (Williston Park). 2013 Jun;27(6):563, 566. No abstract available.

Supplemental Content

Loading ...
Support Center